General Information of This Antigen
Antigen ID
TAR0YOEAI
Antigen Name
Neural cell adhesion molecule 1 (NCAM1)
Gene Name
NCAM1
Synonym
NCAM; CD_antigen=CD56
Sequence
MLQTKDLIWTLFFLGTAVSLQVDIVPSQGEISVGESKFFLCQVAGDAKDKDISWFSPNGE
KLTPNQQRISVVWNDDSSSTLTIYNANIDDAGIYKCVVTGEDGSESEATVNVKIFQKLMF
KNAPTPQEFREGEDAVIVCDVVSSLPPTIIWKHKGRDVILKKDVRFIVLSNNYLQIRGIK
KTDEGTYRCEGRILARGEINFKDIQVIVNVPPTIQARQNIVNATANLGQSVTLVCDAEGF
PEPTMSWTKDGEQIEQEEDDEKYIFSDDSSQLTIKKVDKNDEAEYICIAENKAGEQDATI
HLKVFAKPKITYVENQTAMELEEQVTLTCEASGDPIPSITWRTSTRNISSEEKASWTRPE
KQETLDGHMVVRSHARVSSLTLKSIQYTDAGEYICTASNTIGQDSQSMYLEVQYAPKLQG
PVAVYTWEGNQVNITCEVFAYPSATISWFRDGQLLPSSNYSNIKIYNTPSASYLEVTPDS
ENDFGNYNCTAVNRIGQESLEFILVQADTPSSPSIDQVEPYSSTAQVQFDEPEATGGVPI
LKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAA
SEFKTQPVQGEPSAPKLEGQMGEDGNSIKVNLIKQDDGGSPIRHYLVRYRALSSEWKPEI
RLPSGSDHVMLKSLDWNAEYEVYVVAENQQGKSKAAHFVFRTSAQPTAIPANGSPTSGLS
TGAIVGILIVIFVLLLVVVDITCYFLNKCGLFMCIAVNLCGKAGPGAKGKDMEEGKAAFS
KDESKEPIVEVRTEEERTPNHDGGKHTEPNETTPLTEPEKGPVEAKPECQETETKPAPAE
VKTVPNDATQTKENESKA

    Click to Show/Hide
Function
This protein is a cell adhesion molecule involved in neuron- neuron adhesion, neurite fasciculation, outgrowth of neurites, etc.; (Microbial infection) Acts as a receptor for rabies virus.

    Click to Show/Hide
Uniprot Entry
NCAM1_HUMAN
HGNC ID
HGNC:7656
KEGG ID
hsa:4684
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
ADC Info ADC Name Payload Target Linker Ref
DXC006
CPT113
DNA topoisomerase 1 (TOP1)
A cleavable peptide linker
Lorvotuzumab
ADC Info ADC Name Payload Target Linker Ref
Lorvotuzumab mertansine
DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
HuN901-CC-1065
Rachelmycin
Human Deoxyribonucleic acid (hDNA)
Cleavable disulfide
[1]
Lorvotuzumab-ADC-24-1
Lorvotuzumab-ADC-24-1 payload
Undisclosed
Lorvotuzumab-ADC-24-1 linker
[2]
Lorvotuzumab-ADC-24-2
Lorvotuzumab-ADC-24-2 payload
Undisclosed
Lorvotuzumab-ADC-24-2 linker
[2]
Lorvotuzumab-ADC-24-3
Lorvotuzumab-ADC-24-3 payload
Undisclosed
Lorvotuzumab-ADC-24-3 linker
[2]
Lorvotuzumab-ADC-24-4
Lorvotuzumab-ADC-24-4 payload
Undisclosed
Lorvotuzumab-ADC-24-4 linker
[2]
Lorvotuzumab-ADC-24-5
Lorvotuzumab-ADC-24-5 payload
Undisclosed
Lorvotuzumab-ADC-24-5 linker
[2]
Lorvotuzumab-ADC-24-6
Lorvotuzumab-ADC-24-6 payload
Undisclosed
Lorvotuzumab-ADC-24-6 linker
[2]
Lorvotuzumab-ADC-24-7
Lorvotuzumab-ADC-24-7 payload
Undisclosed
Lorvotuzumab-ADC-24-7 linker
[2]
Lorvotuzumab-ADC-24-8
Lorvotuzumab-ADC-24-8 payload
Undisclosed
Lorvotuzumab-ADC-24-8 linker
[2]
Lorvotuzumab-ADC-24-9
Lorvotuzumab-ADC-24-9 payload
Undisclosed
Lorvotuzumab-ADC-24-9 linker
[2]
Lorvotuzumab-ADC-24-10
Lorvotuzumab-ADC-24-10 payload
Undisclosed
Lorvotuzumab-ADC-24-10 linker
[2]
Lorvotuzumab-ADC-24-11
Lorvotuzumab-ADC-24-11 payload
Undisclosed
Lorvotuzumab-ADC-24-11 linker
[2]
Lorvotuzumab-ADC-24-12
Lorvotuzumab-ADC-24-12 payload
Undisclosed
Lorvotuzumab-ADC-24-12 linker
[2]
Lorvotuzumab-ADC-24-13
Lorvotuzumab-ADC-24-13 payload
Undisclosed
Lorvotuzumab-ADC-24-13 linker
[2]
Promiximab
ADC Info ADC Name Payload Target Linker Ref
Promiximab-DUBA
seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Mal-Val-Cit-PABA-Cyclization spacer
[3]
Promiximab-MMAE
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
[4]
Undisclosed
ADC Info ADC Name Payload Target Linker Ref
Anti-CD56 antibody-drug conjugate (Connectyx)
Undisclosed
Undisclosed
Undisclosed
[5]
EDC-7
Glycosylation scillarenin
Undisclosed
CEN010-105
[6]
References
Ref 1 Enhancement of the selectivity and antitumor efficacy of a CC-1065 analogue through immunoconjugate formation. Cancer Res. 1995 Sep 15;55(18):4079-84.
Ref 2 Ligand-drug conjugate of exatecan analogue, preparation method therefor and application thereof; 2020-04-02.
Ref 3 Promiximab-duocarmycin, a new CD56 antibody-drug conjugates, is highly efficacious in small cell lung cancer xenograft models. Oncotarget. 2017 Dec 26;9(4):5197-5207. doi: 10.18632/oncotarget.23708. eCollection 2018 Jan 12.
Ref 4 Preparation and anti-cancer evaluation of promiximab-MMAE, an anti-CD56 antibody drug conjugate, in small cell lung cancer cell line xenograft models. J Drug Target. 2018 Dec;26(10):905-912. doi: 10.1080/1061186X.2018.1450413. Epub 2018 Apr 13.
Ref 5 Prospective Grant of an Exclusive Patent License: Anti-CD56 as an Antibody-Drug Conjugate (ADC) or Non-ADC To Target Glioblastoma Either Alone or in Combination With Other Potential Immuno-Oncology Drugs.
Ref 6 Introduction to basic information on ADC drug EDC-7